IPOS - Blue Water Vaccine stock plunges 67% still up 115% from IPO price

Blue Water Vaccine (BWV) stock plunged 67% on Thursday in midday action, but is still up 115% from its initial public offering price. Shares of the influenza vaccine developer recently changed hands at $19.39, down 67%, at approximately 12:15 p.m. ET. Blue Water held its initial public offering on Feb. 18. The company raised $20M after offering 2.2M shares at $9 per share, with shares soaring 538% to close their debut session at $57.40. The biotech group has been developing a universal flu vaccine along with vaccines for pneumococcus, norovirus, rotavirus and malaria. On Wednesday, an FDA advisory committee met to discuss how and when COVID-19 booster shots should be offered to the general public.

For further details see:

Blue Water Vaccine stock plunges 67%, still up 115% from IPO price